FIELD: medicine.
SUBSTANCE: invention relates to a compound of the formula (1) or its pharmaceutically acceptable salt. The invention relates to a pharmaceutical composition inhibiting activity of TLR7/8, including effective amount of the compound, according to the invention, or its pharmaceutically acceptable salt and a pharmaceutically acceptable adjuvant, carrier, or filler. The invention also relates to a method for inhibition of activity of TLR7/8 and a method for the treatment of TLR7/8-mediated disorder selected from lupus, polymyositis, dermatomyositis, Sjogren’s disease, and rheumatoid arthritis in a patient, who needs it, including a stage of administration to the specified patient of the compound, according to the invention, or its pharmaceutically acceptable salt.
EFFECT: compound of the formula (1) as antagonists of toll-like receptor 7/8 (TLR7/8).
5 cl, 2 tbl, 141 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOPYRIMIDINE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2826628C1 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
| TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
| QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING SAME | 2011 |
|
RU2582610C2 |
| CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
| BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | 2017 |
|
RU2769827C2 |
| THIAZOLYLPHENYL-BENZENESULFONAMIDO DERIVATIVES AS KINASE INHIBITORS | 2012 |
|
RU2606497C2 |
| SUBSTITUTED PYRIDINE COMPOUND | 2011 |
|
RU2572606C2 |
| GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
| BICYCLIC DIHYDROPYRIMIDINECARBOXAMIDE DERIVATIVES AS RHO-KINASE INHIBITORS | 2017 |
|
RU2778478C2 |
